✦ LIBER ✦

Taking ACTION to establish direct costs and outcomes of treating advanced non-small cell lung cancer in routine clinical practice

✍ Scribed by Cullen, Michael; Szczepura, Ala; Thomas, Michael; Kielhorn, Adrian

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of ERCC1 variants in response to ch

✍ Huang, Shao-jun; Wang, Yu-fei; Jin, Zhi-yong; Sun, Jia-yang; Guo, Zhan-lin 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 265 KB

Histology as a Potential Clinical Predic

✍ Thomas Wibmer, Thierry Berghmans, Cornelia Kropf-Sanchen, Jean-Jacques Lafitte… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 233 KB

Characteristics and outcomes of patients

✍ Tanai, C; Nokihara, H; Yamamoto, S; Kunitoh, H; Yamamoto, N; Sekine, I; Ohe, Y; 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 153 KB

PCN42 POOLING CLINICAL AND COST OUTCOMES

✍ R McAllister; D Meddis; J Jansen; J Ryan; J Brown 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Positron emission tomography with select

✍ Kelvin K. Yap; Kenneth S. K. Yap; Amanda J. Byrne; Salvatore U. Berlangieri; Aur 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 125 KB

PCN9 OBSERVATIONAL STUDY OF PATIENTS WIT

✍ A Vergnenegre; I Monnet; C Chouaid; J Hureaux; J Mazières; G Quéré; JN Lombard; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB